Telomere shortening, which ultimately culminates in cellular senescence, is counteracted by the reverse transcriptase telomerase in stem cells and in about 85% of all cancers, while the remaining cancers maintain telomeres with the recombination‐based alternative lengthening of telomeres (ALT) mechanism. Here, GPT is linked to cancer.